Related Experiment Video
Updated: Aug 8, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Beyond bar charts: A practical guide to small sample pharmacological data
Nancy A Sachs, Michael J Marino1
1Drexel University College of Medicine, Department of Pharmacology & Physiology, United States.
This study offers a practical workflow for analyzing small biological datasets (n<20). It introduces a Visual Trio framework and Dixon's Q-test for objective outlier detection, enhancing data reliability in experimental biology.
Area of Science:
- Pharmacology
- Experimental Biology
- Biostatistics
Background:
- Small datasets (n<20) are common in biological research due to high costs and ethical constraints.
- Estimating population parameters and identifying outliers in small samples is challenging, risking investigator bias with ad-hoc data removal.
- Traditional outlier detection methods often fail with small sample sizes typical in bench science.
Purpose of the Study:
- To provide a structured workflow for exploratory data analysis (EDA) and objective outlier management for biological researchers.
- To introduce a Visual Trio framework and Dixon's Q-test for reliable anomaly detection in small datasets.
- To address left-censored data and promote transparency and reproducibility in small-n studies.
Main Methods:
- Development of a Visual Trio framework (Tukey boxplots, overlaid scatter plots, Confidence Funnels) for data distribution assessment and anomaly identification.
- Application of Dixon's Q-test as an objective diagnostic screen for sensitivity analyses in small samples.
- Inclusion of strategies for handling left-censored assay non-detects via prespecified analyses.
Main Results:
- The Visual Trio framework enables effective assessment of data distribution and identification of potential anomalies in small datasets.
- Dixon's Q-test provides an objective method to guide sensitivity analyses, improving the reliability of findings from small samples.
- The proposed workflow enhances the statistical integrity of small-n experimental data, supporting robust conclusions.
Conclusions:
- This workflow empowers biological researchers to maximize the value of limited experimental data.
- Objective outlier management and sensitivity analyses are crucial for reliable interpretation of small-n study results.
- The provided R code and resources facilitate transparency and reproducibility in small-sample research.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Dosage Regimens: Partial Pharmacokinetic Parameters
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Physiological Models
Therapeutic Drug Monitoring: Drug Analysis Methods
